The CARBOGEN AMCIS Ltd. Manchester facility focuses on process optimization and the synthesis of nonGMP pharmaceutical intermediates. CARBOGEN AMCIS also conducts the development and supply of highly potent APIs to an activity level below 1.0 µg/m³